- Home
- ABVC
ABVC
ABVC BioPharma Inc.
as 05-14-2025 4:00pm EST
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 18.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 248.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.40 - $1.40 | Next Earning Date: | 04-30-2025 |
| Revenue: | $508,383 | Revenue Growth: | 1904.43% |
| Revenue Growth (this year): | 735.18% | Revenue Growth (next year): | N/A |
Latest ABVC BioPharma Inc. News
ABVC Breaking Stock News: Dive into ABVC Ticker-Specific Updates for Smart Investing
NewMediaWire
15 hours ago
ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance
NewMediaWire
6 days ago
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504
NewMediaWire
14 days ago
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan
NewMediaWire
a month ago
UPDATE: ABVC BioPharma Announces 2024 Financial Results
NewMediaWire
a month ago
ABVC BioPharma Announces 2024 Financial Results
NewMediaWire
a month ago
ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
NewMediaWire
2 months ago
ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential
NewMediaWire
2 months ago
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
Compare ABVC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABVC ABVC BioPharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.